bimagrumab semaglutide combination trial Bimagrumab-Semaglutide Combination Achieves Significant Weight Loss While Preserving Muscle Mass

Regeneron's Semaglutide + Trevogrumab Combination: A Game-Changer in Obesity and Metabolic Disease?

21.15

★★★★☆4.8 (126)

A phase 2 clinical trial has demonstrated that bimagrumab, when combined with semaglutide, resulted in significant weight loss for trial participants while maintaining lean muscle mass – suggesting a promising approach for

20.52

★★★★★4.9 (98)

💪 Lose fat, keep the muscle! The BELIEVE Phase 2 trial shows that combining Bimagrumab with Semaglutide leads to 17.8 kg weight loss while preserving lean mass. A game-changer for healthy, sustainable

28.73

★★★★★5.0 (157)

Obesity trials are evolving 👇 New Phase 2 data (Nature Medicine, BELIEVE trial) evaluates bimagrumab ± semaglutide—and highlights a shift beyond weight loss alone. • Focus on fat vs. lean mass •

27.79

★★★★★4.7 (84)

Bimagrumab preserves lean mass and sustains fat loss during semaglutide-induced weight reduction in diet-induced obese mice

28.35

★★★★★4.9 (203)

New phase 2 data just published in Nature Medicine on bimagrumab combined with semaglutide. Swipe for the breakdown. Follow @adam_nessim for more. Source: Heymsfield et al., Nature Medicine, March 2, 2026

29.74

★★★★★5.0 (176)

New drugs for the treatment of obesity: do we need approaches to preserve muscle mass? | Reviews in Endocrine and Metabolic Disorders

23.08

★★★★★4.8 (132)